To explore how estrogen deficiency impacts the blood pressure (BP) and sympathetic nerve activity (SNA), and how it impacts the production of the key pro-inflammatory mediators such as Tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). It is hypothesized that estrogen deficiency increases BP, SNA and the pathway activities of the key pro-inflammatory mediators. Those effects are impacted through the downregulation of the estrogen receptor.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Red blood cell flux
Timeframe: Recorded continuously for up to 4 hours during the study visit
Mean arterial pressure (mmHg)
Timeframe: Recorded continuously for up to 4 hours during the study visit
baseline plasma TNF-α concentration (pg/ml)
Timeframe: Upon participants' arrival to the first study visit up to 5 minutes
One week post-intervention plasma TNF-α concentration (pg/ml)
Timeframe: Upon participants' arrival to the second study visit (1 week after the first visit)
baseline plasma IL-1β concentration (pg/ml)
Timeframe: Upon participants' arrival to the first study visits up to 5 minutes
One week post-intervention plasma IL-1β concentration (pg/ml)
Timeframe: Upon participants' arrival to the second study visit (1 week after the first visit)
baseline plasma IL-6 concentration (pg/ml)
Timeframe: Upon participants' arrival to the first study visits up to 5 minutes
One week post-intervention plasma IL-6 concentration (pg/ml)
Timeframe: Upon participants' arrival to the second study visit (1 week after the first visit)